Schedule 13G ownership disclosure
NLS PHARMACEUTICS LTD
Security class unavailable · CUSIP: H57830103
Event date: 2021-03-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-21-003638
- Form type
- SC 13G
- Filer
- HIRSCHMAN ORIN
- CIK
- CIK 1131362
- Filed
- Mar 17, 2021
- Reporting period
- Mar 12, 2021
- Description
- Schedule 13G beneficial ownership